BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22214453)

  • 1. Molecular response to hypericin-induced photodamage.
    Krammer B; Verwanger T
    Curr Med Chem; 2012; 19(6):793-8. PubMed ID: 22214453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
    Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
    Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericin in cancer treatment: more light on the way.
    Agostinis P; Vantieghem A; Merlevede W; de Witte PA
    Int J Biochem Cell Biol; 2002 Mar; 34(3):221-41. PubMed ID: 11849990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
    Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
    Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
    Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multifaceted photocytotoxic profile of hypericin.
    Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
    Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin.
    Sanovic R; Krammer B; Grumboeck S; Verwanger T
    Int J Oncol; 2009 Oct; 35(4):921-39. PubMed ID: 19724930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.
    Ocker L; Adamus A; Hempfling L; Wagner B; Vahdad R; Verburg FA; Luster M; Schurrat T; Bier D; Frank M; Lisec J; Engel N; Seitz G
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101588. PubMed ID: 31704507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
    Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
    Kleban J; Mikes J; Horváth V; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
    J Photochem Photobiol B; 2008 Nov; 93(2):108-18. PubMed ID: 18771933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy.
    Lin S; Yang L; Shi H; Du W; Qi Y; Qiu C; Liang X; Shi W; Liu J
    Int J Biochem Cell Biol; 2017 Jun; 87():54-68. PubMed ID: 28392376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers.
    Piette J; Volanti C; Vantieghem A; Matroule JY; Habraken Y; Agostinis P
    Biochem Pharmacol; 2003 Oct; 66(8):1651-9. PubMed ID: 14555246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
    Popovic A; Wiggins T; Davids LM
    J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
    Mikešová L; Mikeš J; Kovaľ J; Gyurászová K; Culka L; Vargová J; Valeková B; Fedoročko P
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):470-83. PubMed ID: 24284100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment.
    Lu Z; Tao Y; Zhou Z; Zhang J; Li C; Ou L; Zhao B
    Free Radic Biol Med; 2006 Nov; 41(10):1590-605. PubMed ID: 17045927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY; Olivo M; Tan BK; Bay BH
    Cancer Lett; 2004 Apr; 207(2):175-81. PubMed ID: 15072826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy.
    Buytaert E; Callewaert G; Hendrickx N; Scorrano L; Hartmann D; Missiaen L; Vandenheede JR; Heirman I; Grooten J; Agostinis P
    FASEB J; 2006 Apr; 20(6):756-8. PubMed ID: 16455754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy.
    Kocanova S; Buytaert E; Matroule JY; Piette J; Golab J; de Witte P; Agostinis P
    Apoptosis; 2007 Apr; 12(4):731-41. PubMed ID: 17219054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
    Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
    Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.